Search
E1v1.11
go.drugbank.com/drugs/DB18363ExperimentalE1v1.11 is an antisense oligonucleotide targeting the _SMN2_ gene which is under investigation for the treatment of spinal muscular atrophy (SMA).[L48196]
Bexotegrast
go.drugbank.com/drugs/DB16515InvestigationalThe compound was granted orphan drug designation by the US FDA in August 2018 for treatment of IPF, and Pliant Therapeutics recently raised $100 million in Series C financing to support further clinical
Cipepofol
go.drugbank.com/drugs/DB16295ApprovedInvestigational[L63931] Cipepofol is approved in the United States for induction of general anesthesia in adults undergoing surgery, an approval Haisco announced on June 1, 2026. … Cipepofol is an intravenous general anesthetic of the alkylphenol class, supplied as a sterile lipid emulsion, which is thought to act by positively modulating the inhibitory function of GABA at ligand-gated
Viquidacin
go.drugbank.com/drugs/DB19549ExperimentalViquidacin has a monoisotopic molecular weight of 504.16 Da.
Galamustine
go.drugbank.com/drugs/DB21062ExperimentalGalamustine has a monoisotopic molecular weight of 303.06 Da.
Dicirenone
go.drugbank.com/drugs/DB20938ExperimentalDicirenone has a monoisotopic molecular weight of 428.26 Da.
Elmustine
go.drugbank.com/drugs/DB20979ExperimentalElmustine has a monoisotopic molecular weight of 195.04 Da.
Fenaperone
go.drugbank.com/drugs/DB21281ExperimentalFenaperone has a monoisotopic molecular weight of 376.22 Da.
Metrenperone
go.drugbank.com/drugs/DB21312ExperimentalMetrenperone has a monoisotopic molecular weight of 407.2 Da.
Acefylline clofibrol
go.drugbank.com/drugs/DB21353ExperimentalAcefylline clofibrol has a monoisotopic molecular weight of 420.12 Da.